Comparative efficacy of 5 sodium glucose cotransporter 2 inhibitor and 7 glucagon-like peptide 1 receptor agonists interventions on cardiorenal outcomes in type 2 diabetes patients: A network meta-analysis based on cardiovascular or renal outcome trials

BACKGROUND: Sodium glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have been demonstrated to be able to improve the cardiovascular and renal prognosis in patients with type 2 diabetes (T2D). However, the relative efficacy of various SGLT2 inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xue-Yan, Liu, Shu-Yan, Yin, Dao-Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322563/
https://www.ncbi.nlm.nih.gov/pubmed/34397684
http://dx.doi.org/10.1097/MD.0000000000026431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322563/
https://www.ncbi.nlm.nih.gov/pubmed/34397684
http://dx.doi.org/10.1097/MD.0000000000026431

Ejemplares similares